You just read:

Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-2 Trial Of Evolocumab (AMG 145) In Statin Intolerant Patients With High Cholesterol

News provided by

Amgen

Jan 23, 2014, 09:15 EST